Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A GITRL-mTORC1-GM-CSF Positive Loop Promotes Pathogenic Th17 Response in Primary Sjögren Syndrome. | Arthritis Rheumatol | 2024 | 38589318 | PubTator, text mining | PubMed |
| A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study. | BMC Cancer | 2024 | 38561648 | PubTator, text mining | PubMed |
| OX40/OX40 ligand and its role in precision immune oncology. | Cancer Metastasis Rev | 2024 | 38526805 | PubTator, text mining | PubMed |
| Single-cell transcriptomic and T cell antigen receptor analysis of human cytomegalovirus (hCMV)-specific memory T cells reveals effectors and pre-effectors of CD8+- and CD4+-cytotoxic T cells. | Immunology | 2024 | 38501302 | PubTator, text mining | PubMed |
| Utility and impact of quantitative pharmacology on dose selection and clinical development of immuno-oncology therapy. | Cancer Chemother Pharmacol | 2024 | 38430307 | PubTator, text mining | PubMed |
| Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine. | Nat Rev Clin Oncol | 2024 | 38424196 | PubTator, text mining | PubMed |
| TCR-like antibody and GITR signaling lead to effective CAR-T against solid tumor. | Mol Ther | 2024 | 38382528 | PubTator, text mining | PubMed |
| Cross-talk between disulfidptosis and immune check point genes defines the tumor microenvironment for the prediction of prognosis and immunotherapies in glioblastoma. | Sci Rep | 2024 | 38365809 | PubTator, text mining | PubMed |
| Dynamics of Whole Transcriptome Analysis (WTA) and Surface markers expression (AbSeq) in Immune Cells of COVID-19 Patients and Recovered captured through Single Cell Genomics. | Front Med (Lausanne) | 2024 | 38357647 | PubTator, text mining | PubMed |
| Effects of High Efficacy Multiple Sclerosis Disease Modifying Drugs on the Immune Synapse: A Systematic Review. | Curr Pharm Des | 2024 | 38343058 | PubTator, text mining | PubMed |
| APOB is a potential prognostic biomarker in hepatocellular carcinoma. | Discov Oncol | 2024 | 38310202 | PubTator, text mining | PubMed |
| Current state of immune checkpoints therapy for glioblastoma. | Heliyon | 2024 | 38298707 | PubTator, text mining | PubMed |
| Progress in mechanism-based diagnosis and treatment of tuberculosis comorbid with tumor. | Front Immunol | 2024 | 38298194 | PubTator, text mining | PubMed |
| Sulforaphane activates CD8+ T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis'. | J Immunother Cancer | 2024 | 38296593 | PubTator, text mining | PubMed |
| Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions. | Genome Med | 2024 | 38281962 | PubTator, text mining | PubMed |
| The implications of FASN in immune cell biology and related diseases. | Cell Death Dis | 2024 | 38272906 | PubTator, text mining | PubMed |
| Role of prognostic gene DKK1 in oral squamous cell carcinoma. | Oncol Lett | 2024 | 38268623 | PubTator, text mining | PubMed |
| A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines. | Cancers (Basel) | 2024 | 38254823 | PubTator, text mining | PubMed |
| Preclinical evaluation of a novel CAR-T therapy utilizing a scFv antibody highly specific to MAGE-A4p230-239/HLA-A∗02:01 complex. | Mol Ther | 2024 | 38243600 | PubTator, text mining | PubMed |
| Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. | Cancer Immunol Immunother | 2024 | 38231448 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=9